EPLAW PATENT BLOG

NL – Bayer v. Dutch Patent Office

Posted: February 23rd, 2017

Bayer v. Dutch Patent Office, 1 February 2017, Case no. ECLI:NL:RBDHA:2017:793 Interpretation of CJEU Neurim. Does a market authorisation for Climodien prevent the obtaining of an SPC for the application of the two active substances for which a later market authorisation for a different pharmaceutical product was obtained? The Court rules that a patented new therapeutic […]

READ MORE

GR – Novartis & Novartis Hellas v. GPH

Posted: February 16th, 2017

Novartis AG & Novartis Hellas SA v. GPH Ltd, Greece , First Instance Court of Athens (temporary relief proceedings), 21 December 2016, Judgment No. 8512/2016 Novartis AG and its Greek subsidiary, Novartis Hellas,  initiated successful temporary relief proceedings against GPH Ltd in defense of their rights to EP No. 2292219 (EP 219), which covers a […]

READ MORE

UK – Jushi Group v. OCV Intellectual Capital

Posted: February 16th, 2017

Jushi Group Co., Ltd v OCV Intellectual Capital, LLC, Intellectual Property Enterprise Court (HHJ Hacon), 6 February 2017, Neutral Citation Number [2017] EWHC 171 (IPEC) This case is interesting for the approach taken by the UK court in a situation where the patent in suit claims ranges that overlap with ranges disclosed in the prior […]

READ MORE

NL – ARCHOS v. KONINKLIJKE PHILIPS / FRAND

Posted: February 14th, 2017

Archos S.A. v. Koninklijke Philips N.V., NL, District Court of The Hague, 10 February 2017, citation number: ECLI:NL:RBDHA:2017:1025 Prior to this case, Philips had brought three patent infringement cases regarding UMTS SEPs against Archos in the Dutch court’s accelerated regime. In response, Archos filed this case on the merits, purely regarding the FRAND questions at […]

READ MORE

UK – Wobben v Siemens / Appeal

Posted: February 10th, 2017

Wobben Properties GmbH v. Siemens plc & Ors, UK, Court of Appeal (Civil Division), Kitchin LJ, Longmore LJ, Floyd LJ, 19 January 2017, Neutral Citation Number: [2017] EWCA Civ 5 This is an appeal against the judgment of Birss J of 20 July 2015, in which he held that Wobben’s patent was invalid for lack […]

READ MORE

UK – Arrow declarations 2 – AbbVie’s second shot also misses the target

Posted: February 6th, 2017

Fujifilm Kyowa Kirin Biologics Co., Ltd (1) Samsung Bioepis UK Ltd), (2) Biogen Idec Ltd v AbbVie Biotechnology Ltd [2016] EWHC 3383 (Ch) Warming to its theme (see earlier post), the English Patents Court gave yet another judgment concerning Arrow declarations in the ongoing litigation between FKB and AbbVie regarding biosimilar adalimumab. This was heard […]

READ MORE

UK – Arrow declarations 1 – AbbVie misses with its first shot

Posted: February 6th, 2017

Fujifilm Kyowa Kirin Biologics Co., Ltd v AbbVie Biotechnology Ltd & AbbVie Ltd [2017] EWCA Civ 1 Regular readers will have noted that one of the themes of the English Patents Court in 2016 has been the resurrection of so-called Arrow declarations, in which a party seeks certainty in relation to pending patent applications by […]

READ MORE

UPC – Finalizing the Unitary Patent Package: Symposium

Posted: January 31st, 2017

Finalizing the Unitary Patent Package: Challenges and Ways Forward, Thon Hotel Brussels City Centre, Brussels, Wednesday 8 February 2017 Speakers include: Prof. Willem A. Hoyng Lawyer, HOYNG ROKH MONEGIER, Amsterdam Katalin Lubóczki Member, UPC Preparatory Committee, Attaché for Intellectual Property, Audiovisual Policy and Consumer Protection Permanent Representation of Hungary to the EU Darren Smyth Partner, […]

READ MORE

NO – Pharmaq v. Intervet

Posted: January 31st, 2017

Pharmaq AS v. Intervet International B.V., Borgarting Court of Appeal, Norway, 19 December 2016, Case Nos. 15-170539ASD-BORG/01 and 15-204605ASD-BORG/01 Intervet International B.v. (“Intervet”), a subsidiary of MSD, was the proprietor of Norwegian patent NO 317 547 which expired 15 October 2015. Claim 1 and 4 of the patent was formulated as follows: “1. A virus […]

READ MORE

EPLAW – Save the date: Global Series 2017 London

Posted: January 30th, 2017

Global Series 2017 Europe (in cooperation with EPLAW) hosts a special session on 25 and 26 September 2017, in London. Global Series sessions, part of an on-going dialogue, address topics of global significance at a senior level of discussion. Working closely with government representatives, adjudicators, corporate leaders, litigation leaders, academics, and others in the global […]

READ MORE